Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after

Dawod Sharif1,2, Mira Abu-Salem2, Amal Sharif-Rasslan2,3

  • 11 Cardiology Department, Bnai Zion Medical Center, Israel.

Insights

Lower platelet counts in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention indicate better coronary flow and myocardial perfusion. Conversely, higher platelet counts are associated with impaired left ventricular systolic function.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Hematology

Background:

  • Elevated platelet counts in ST-elevation myocardial infarction (STEMI) patients treated with fibrinolysis correlate with poorer clinical outcomes.
  • Primary percutaneous coronary intervention (PCI) is a key treatment for acute STEMI.

Purpose of the Study:

  • To investigate the impact of admission platelet count on coronary flow, myocardial perfusion, and left ventricular systolic function recovery in STEMI patients treated with primary PCI.
  • To test the hypothesis that platelet count influences key indicators of cardiac recovery post-primary PCI.

Main Methods:

  • 174 anterior STEMI patients undergoing primary PCI were stratified into four platelet count groups: <200 K, 200-300 K, 300-400 K, and >400 K.
  • Coronary artery flow and myocardial blush were assessed using TIMI criteria.
  • Doppler echocardiography evaluated left anterior descending (LAD) coronary artery velocities and left ventricular (LV) function (ejection fraction, WMSI) pre- and post-PCI.

Main Results:

  • Post-PCI TIMI flow, myocardial blush, and ST elevation resolution were comparable across all platelet count groups.
  • Patients with platelet counts <200 K exhibited higher peak diastolic LAD velocities and a greater incidence of LAD velocity deceleration time >600 ms, suggesting improved myocardial perfusion.
  • Patients with platelet counts >400 K showed significantly worse LV ejection fraction and WMSI, both at admission and pre-discharge.

Conclusions:

  • Lower admission platelet counts in STEMI patients treated with primary PCI are associated with enhanced coronary diastolic velocities and improved myocardial perfusion.
  • Higher platelet counts are linked to diminished left ventricular systolic function in STEMI patients undergoing primary PCI.
  • Platelet count serves as a potential prognostic marker in STEMI patients treated with primary PCI, influencing cardiac recovery and function.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395